Hyperfine, Inc. Reports First Quarter 2025 Financial Results. GUILFORD, Conn., May 13, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that ...

Earnings Call Insights: Hyperfine, Inc. (HYPR) Q1 2025 Management View President and CEO Maria Sainz reported first quarter revenue of $2.1 million from six system sales, noting this quarter marks ...

Hyperfine, Inc. will host a conference call at 1:30 p.m. PT/ 4:30 p.m. ET on Monday, March 17, 2025, to discuss its fourth quarter and full year 2024 financial results and provide a business update.

Hyperfine, Inc. (NASDAQ:HYPR), a medical device company specializing in electromedical apparatus, disclosed on Tuesday that it is undergoing an organizational restructuring that includes the ...

GUILFORD, Conn., March 06, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared ...

Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking health technology company that has redefined brain imaging with the Swoop® system—the first FDA-cleared, portable, ultra-low-field, magnetic ...

Hyperfine (NASDAQ:HYPR) is aiming to 'democratize' access to MRIs with the help of selling a bedside, low-energy MRI scanner called the Swoop. This is an invention of serial inventor and company ...

Hyperfine, Inc. (NASDAQ:HYPR) Q4 2024 Results Conference Call March 17, 2025 4:30 PM ETCompany ParticipantsMarissa Bych - Gilmartin GroupMaria Sainz - ...

Hyperfine In this new study, researchers from Yale Medicine tested the efficacy of the new MRI device in 30 patients admitted to Yale New Haven Hospital’s neuroscience intensive care unit.

Hyperfine, Inc. (HYPR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces ...